Novo
PulseAugur coverage of Novo — every cluster mentioning Novo across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
GLP-1 drugs poised to outpace AI in impact and revenue
GLP-1 drugs are projected to have a more significant impact than artificial intelligence over the next two years, with sales expected to surpass generative AI revenue by the end of 2025. While initial costs were high, p…
-
Global interest in Chinese biotech surges with major pharma deals
Global interest in Chinese biotech is rising, evidenced by significant deals involving major pharmaceutical companies. AstraZeneca is investing $2 billion in Summit Therapeutics, which is advancing Akeso's immunotherapy…
-
Ozempic-maker Novo Nordisk rebrands to 'Novo' amid competition
Novo Nordisk, the pharmaceutical company known for its weight-loss drugs Ozempic and Wegovy, is rebranding to simply 'Novo'. This change aims to make the brand more memorable and relevant for consumers as the company fa…